Arrowhead Pharmaceuticals, Inc. is a commercial stage biopharmaceutical company focused on developing medicines for intractable diseases by silencing the genes that cause them. The company utilizes a broad portfolio of RNA chemistries and efficient modes of delivery to trigger the RNA interference mechanism for rapid, deep, and durable knockdown of target genes. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing. The company is dedicated to developing innovative drugs for diseases with a genetic basis, often characterized by the overproduction of disease-involved proteins. Arrowhead's technologies enable the potential to address conditions in virtually any therapeutic area and pursue disease targets not addressable by small molecules and biologics. The company is a leader in bringing RNAi to address diseases outside of the liver, with a clinical pipeline including liver and lung disease targets and promising preclinical candidates. Arrowhead's corporate headquarters are in Pasadena, CA, with R&D teams in Madison, WI & San Diego, CA, and a manufacturing facility in Verona, WI. The company values nimble, science-driven innovators who collaborate to bring new therapies to patients. This specific role is for a highly energetic and self-motivated Clinical Finance Senior Analyst who will engage with CROs and sites to review and approve global site budgets for phase I-IV clinical trials. The incumbent will also assist in reviewing site contracts and other study-related documents. The position reports to Arrowhead’s Clinical Finance Manager and will collaborate with internal stakeholders to achieve business objectives and deliverables. This is a full-time, onsite position at Arrowhead’s Corporate Headquarters in Pasadena, CA.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior